SW1353Homo sapiens (Human)Cancer cell line

Also known as: SW 1353, SW-1353

🤖 AI SummaryBased on 12 publications

Quick Overview

SW1353 is a chondrosarcoma cell line used in cancer research.

Detailed Summary

SW1353 is a chondrosarcoma cell line derived from a human tumor. It is commonly used in research to study the molecular mechanisms of chondrosarcoma and to test potential therapeutic strategies. The cell line has been characterized in multiple studies, including those focusing on genetic mutations, drug sensitivity, and cellular responses to various treatments. Research involving SW1353 has contributed to understanding the role of IDH1 and IDH2 mutations in cancer progression and has been utilized in studies related to sarcoma and other mesenchymal tumors. Additionally, SW1353 has been used in investigations of genomic instability and its implications for cancer treatment.

Research Applications

Cancer researchGenetic mutation studiesDrug sensitivity testingGenomic instability analysis

Key Characteristics

IDH1 and IDH2 mutationsChondrosarcoma originUsed in sarcoma research
Generated on 6/15/2025

Basic Information

Database IDCVCL_0543
SpeciesHomo sapiens (Human)
Tissue SourceBone, right humerus[UBERON:UBERON_0000976]

Donor Information

Age72
Age CategoryAdult
SexFemale
Racecaucasian

Disease Information

DiseaseChondrosarcoma
LineageBone
SubtypeChondrosarcoma
OncoTree CodeCHS

DepMap Information

Source TypeATCC
Source IDACH-000418_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Val203Leu (c.607G>C)Heterozygous-Unknown, PubMed=19787792
MutationSimpleIDH2p.Arg172Ser (c.516G>C)Heterozygous-Unknown, PubMed=22057234

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
12
D10S1248
13,16
D12S391
22,23
D13S317
12,13
D16S539
11,12
D18S51
13,17
D19S433
14
D1S1656
11,17.3
D21S11
30,32.2
D22S1045
15,17
D2S1338
19,24
D2S441
11,14
D3S1358
15,18
D5S818
10,11
D7S820
9,11
D8S1179
10,11
FGA
22,23
Penta D
10,11
Penta E
12,14
SE33
19,21
TH01
6,9
TPOX
8,11
vWA
16,17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Sister chromatid exchange and genomic instability in soft tissue sarcomas: potential implications for response to DNA-damaging treatments.

Salawu A., Wright K., Al-Kathiri A., Wyld L., Reed M.W.R., Sisley K.

Sarcoma 2018:3082526.1-3082526.8(2018).

Characterization of human cancer cell lines by reverse-phase protein arrays.

Liang H.

Cancer Cell 31:225-239(2017).

Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC dependence in intrahepatic cholangiocarcinoma.

Bardeesy N.M.

Cancer Discov. 6:727-739(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Sarcoma cell line screen of oncology drugs and investigational agents identifies patterns associated with gene and microRNA expression.

Harris E., Monks A., Morris J.

Mol. Cancer Ther. 14:2452-2462(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.

Kurek K.C., Szuhai K., French P.J., Bovee J.V.M.G.

Nat. Genet. 43:1256-1261(2011).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.

Buerger H., Aigner T., Gabbert H.E., Poremba C.

Genes Chromosomes Cancer 49:40-51(2010).

Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1beta.

Bartnik E., Beninga J., Zimmer R., Aigner T.

Osteoarthritis Cartilage 13:697-708(2005).

Human tumor lines for cancer research.";

Fogh J.

Cancer Invest. 4:157-184(1986).

Development, availability and characterization of ATCC human and animal cell lines.

Hay R.J.

(In book chapter) Animal cell culture and production of biologicals; Sasaki R., Ikura K. (eds.); pp.27-39; Springer; Dordrecht; Netherlands (1991).

Web Resources